Neoprobe Corporation

News and overview for Neoprobe Corporation

Neoprobe Announces Third Quarter Results [Press Release]
Business Wire | 22 days 6 hours 53 minutes ago
Neoprobe Corporation (OTCBB:NEOP), a diversified developer of innovative oncology surgical and diagnostic products, today announced consolidated results for the third quarter of 2009 and for the nine-month period ended September 30, 2009. Neoprobe’s revenues for the third quarter of 2009 were $2.6 million compared to $1.7 million for the third quarter of 2008. Year-to-date revenues for the nine-month period ended September 30, 2009 were $7.1 million compared to $5.6 million for the same perio...


Laureate Pharma and Neoprobe Corporation Announce Manufacturing Alliance [Press Release]
PRNewswire | 77 days 11 hours 21 minutes ago
Laureate Pharma and Neoprobe Corporation Announce Manufacturing Alliance - Laureate to Manufacture Neoprobe's RIGScan(R) CR Monoclonal...Sept. 8 /PRNewswire/ -- Neoprobe Corporation , a diversified developer of...


Neoprobe 3rd Quarter and Business Update Conference Call Invitation [Press Release]
Business Wire | 27 days 12 hours 3 minutes ago
Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology surgical and diagnostic products, today announced it would report its financial results for the third quarter of 2009 on Monday, November 2, 2009 after the close of the financial markets. The Company has scheduled a conference call with the investment community to discuss the financial results for the following morning, Tuesday, November 3, 2009 at 11:00 AM ET.


Neoprobe to Present at Oppenheimer Healthcare Conference [Press Release]
Business Wire | 28 days 15 hours 24 minutes ago
Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology surgical and diagnostic products, today announced that its President and Chief Executive Officer, David Bupp, will present on Wednesday, November 4th, 2009 at 4:30PM ET during the 20th Annual Oppenheimer Healthcare Conference to be held at the Waldorf Hotel in New York, New York. Mr. Bupp’s presentation will provide an overview of the Company’s technology and business strategy including information on its marke...


Research and Markets: Blood Flow Measurement Devices - Global Market Opportunities [Press Release]
Business Wire | 5 days 14 hours 38 minutes ago
Research and Markets (http://www.researchandmarkets.com/research/f042ea/blood_flow_measure) has announced the addition of the "Blood Flow Measurement Devices - Global Market Opportunities" report to their offering.





 1  

5 Results

Sign up for AdvaMed SmartBrief



Designed specifically for manufacturers of medical devices, health care information systems and diagnostic products, AdvaMed SmartBrief is a FREE e-mail newsletter. By providing a summary of the day's most important medical technologies news, AdvaMed SmartBrief saves you time and keeps you smart. Learn more

Company Overview


Company: Neoprobe Corporation
Industry: Medical Equipment & Supplies
Website: http://www.neoprobe.com

Neoprobe makes products for the diagnosis and treatment of cancer, such as lymphatic mapping instruments (including the neo2000) that help surgeons identify trends about the spread of cancer in a patient. Subsidiary Cardiosonix markets non-invasive blood flow measurement devices under the Quantix brand. Neoprobe has additional products under development including procedural tracing agent Lymphoseek to be used in lymphatic mapping and handheld radiation probe RIGScan to locate tumors. The company is also working on an activated cellular therapy technology to treat cancers and viral and autoimmune diseases. The procedure activates certain lymph nodes to boost a patient's immune system.


Key Numbers

Sales in U.S. Dollars (mil.) 7.9 (2008)
One-year % Growth in Sales 10.7 (2008)
Net Income in U.S. Dollars (mil.) -5.2 (2008)
One-year % Growth in Net Income 0.0 (2008)
Number of Employees 25 (2008)
One-year % Growth in Number of Employees 19.0 (2008)
Fiscal Year-End December